JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

80 hedge funds and large institutions have $122M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 5 closing their positions.

Holders
80
Holders Change
Holders Change %
0%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
7
Increased
27
Reduced
31
Closed
5
Calls
$161K
Puts
$58K
Net Calls
+$103K
Net Calls Change
-$68K